Skip to main content
Top
Published in: Kidney 5/2009

01-09-2009

Heart Rate Variability in Patients with Diabetic Nephropathy

Authors: Emam Waked, Amna Metwaly, Emad Abd Allah, Heba Sayed Assal, Khaled Younes

Published in: Kidney | Issue 5/2009

Login to get access

Abstract

Background

Patients with diabetic nephropathy are likely to have neurological complications including cardiovascular autonomic dysfunction, which is related to increased risk of mortality and it probably had an earlier onset and may precede the appearance of autonomic symptoms. The aim of this study was to assess cardiovascular autonomic functions by using heart rate variability analysis and its relationship with left ventricular function in type 2 diabetic patients with and without nephropathy.

Materials and Methods

This study was conducted on 45 diabetic patients, 15 without nephropathy, 15 with nephropathy and 15 diabetic nephropathy on hemodialysis, as well as 15 age- and sex-matched healthy controls. All of them were subjected to analysis of heart rate variability (HRV) by Holter ECG, Echocardiography, and analysis of the lipid profile.

Results

All time domain and frequency domain measures of HRV were significantly reduced in diabetic patients with and without nephropathy compared to healthy controls (p < 0.0001). There was a significant decrease in ejection fraction (EF) and increase in left ventricular mass index (LVMI) in diabetic patients with and without nephropathy compared to healthy controls (p < 0.0001). Also there was a significant increase in cholesterol, triglycerides and LDL with significant decrease in HDL in diabetic patients with and without nephropathy compared to healthy controls (p < 0.0001).

Conclusion

Cardiac autonomic dysfunction (as manifested by decreased HRV) was demonstrated in diabetic patients and its degree was enhanced in patients with nephropathy than in those without.
Literature
1.
go back to reference Nishimura M, Hashimoto T, Kobayashi H, et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic hemodialysis patients. Nephrol Dial Transplant. 2004;19:2532–8.CrossRefPubMed Nishimura M, Hashimoto T, Kobayashi H, et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic hemodialysis patients. Nephrol Dial Transplant. 2004;19:2532–8.CrossRefPubMed
2.
go back to reference Freeman R. Diabetic autonomic neuropathy: an overview. In: Veves A, editor. Clinical management of diabetic neuropathy. Totowa, NJ: Humana; 1998. p. 181–208. Freeman R. Diabetic autonomic neuropathy: an overview. In: Veves A, editor. Clinical management of diabetic neuropathy. Totowa, NJ: Humana; 1998. p. 181–208.
3.
go back to reference Van Ravenswaaij-Arts CMA, Kollée LAA, Hopman JCW, Stoelinga GBA, van Geijn HP. Heart rate variability. Ann Intern Med. 1993;118:436–47.PubMed Van Ravenswaaij-Arts CMA, Kollée LAA, Hopman JCW, Stoelinga GBA, van Geijn HP. Heart rate variability. Ann Intern Med. 1993;118:436–47.PubMed
4.
go back to reference Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95–108.PubMed Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95–108.PubMed
5.
go back to reference O’Brien IA, McFadden JP, Corrall RJM. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med. 1991;79:495–502.PubMed O’Brien IA, McFadden JP, Corrall RJM. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med. 1991;79:495–502.PubMed
6.
go back to reference Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract. 2002;58:131–8.CrossRefPubMed Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract. 2002;58:131–8.CrossRefPubMed
7.
go back to reference Pfeifer MA, Weinberg CR, Cook CL, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care. 1984;7:447–53.CrossRefPubMed Pfeifer MA, Weinberg CR, Cook CL, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care. 1984;7:447–53.CrossRefPubMed
8.
go back to reference Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043–65. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043–65.
9.
go back to reference American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2001;24(1):S58–61.CrossRef American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2001;24(1):S58–61.CrossRef
10.
go back to reference Risk M, Boil V, Broadbridge C, Cohen A. Heart rate variability measurement in diabetic neuropathy: review of methods. Dial Technol Ther. 2001;3:63–76.CrossRef Risk M, Boil V, Broadbridge C, Cohen A. Heart rate variability measurement in diabetic neuropathy: review of methods. Dial Technol Ther. 2001;3:63–76.CrossRef
11.
go back to reference Giannini C, Dyck PJ. Pathologic alterations in human diabetic polyneuropathy. In: Dyck PJ, Thomas PK, editors. Diabetic neuropathy. 2nd ed. Philadelphia: W.B. Saunders; 1999. p. 279–95. Giannini C, Dyck PJ. Pathologic alterations in human diabetic polyneuropathy. In: Dyck PJ, Thomas PK, editors. Diabetic neuropathy. 2nd ed. Philadelphia: W.B. Saunders; 1999. p. 279–95.
12.
go back to reference Prichard S. Impact of dyslipidemia in end stage renal disease. Am Soc Nephrol. 2003;14:S315–20.CrossRef Prichard S. Impact of dyslipidemia in end stage renal disease. Am Soc Nephrol. 2003;14:S315–20.CrossRef
13.
go back to reference Gang H, Pekka J, Noël B, Qing Q, Timo I, Jaakko T. Physical activity, cardiovascular risk factors, and mortality among finnish adults with diabetes. Diabetes Care. 2005;28(4):799–805.CrossRef Gang H, Pekka J, Noël B, Qing Q, Timo I, Jaakko T. Physical activity, cardiovascular risk factors, and mortality among finnish adults with diabetes. Diabetes Care. 2005;28(4):799–805.CrossRef
14.
go back to reference Fried L, Orchard T, Kasiske B. Effect of lipid reduction on the progression of renal disease: a Meta analysis. Kid. Int. 2001;59:260–9.CrossRef Fried L, Orchard T, Kasiske B. Effect of lipid reduction on the progression of renal disease: a Meta analysis. Kid. Int. 2001;59:260–9.CrossRef
15.
go back to reference Bodlaj G, Berg J, Pichler R, Sailer T, Biesenbach G. Type 2 diabetes in patients with end stage renal disease is not associated with further increased serum inflammatory parameters. J Nephrol. 2004;17(Supp. 1):112–7.PubMed Bodlaj G, Berg J, Pichler R, Sailer T, Biesenbach G. Type 2 diabetes in patients with end stage renal disease is not associated with further increased serum inflammatory parameters. J Nephrol. 2004;17(Supp. 1):112–7.PubMed
16.
go back to reference Lakatta E, Levy D. Arterial and cardiac aging: major shareholders in 9 cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–54.CrossRefPubMed Lakatta E, Levy D. Arterial and cardiac aging: major shareholders in 9 cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–54.CrossRefPubMed
17.
go back to reference Henry R, Otto K, Kostense P, et al. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: Independence of increased arterial stiffness or decreased flow mediated dilation. Diabetes Care. 2004;27:522–9.CrossRefPubMed Henry R, Otto K, Kostense P, et al. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: Independence of increased arterial stiffness or decreased flow mediated dilation. Diabetes Care. 2004;27:522–9.CrossRefPubMed
18.
go back to reference Valensi P, Johnson B, Blanche M, Extramania F, Motte G, Coumel P. Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular depolarization diabetic patients. Diabetes Care. 2002;25:918–23.CrossRefPubMed Valensi P, Johnson B, Blanche M, Extramania F, Motte G, Coumel P. Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular depolarization diabetic patients. Diabetes Care. 2002;25:918–23.CrossRefPubMed
19.
go back to reference Viswanathan V, Prasad D, Chamukuttan S, Ramachandran A. High prevalence and early onset of cardiac autonomic neuropathy among South Indian type 2 diabetic patients with nephropathy. Diabetes Res Clin Pract. 2000;48(3):211–6.CrossRefPubMed Viswanathan V, Prasad D, Chamukuttan S, Ramachandran A. High prevalence and early onset of cardiac autonomic neuropathy among South Indian type 2 diabetic patients with nephropathy. Diabetes Res Clin Pract. 2000;48(3):211–6.CrossRefPubMed
20.
go back to reference Giordano M, Manzella D, Paolisso G, Calendo A, Varricchio M, Giordano C. Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant. 2001;16(3):566–73.CrossRefPubMed Giordano M, Manzella D, Paolisso G, Calendo A, Varricchio M, Giordano C. Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant. 2001;16(3):566–73.CrossRefPubMed
21.
go back to reference Gottsater A, Ahmed M, Fernlund P, Sundkvist G. Autonomic neuropathy in type 2 diabetic patients is associated with hyperinsulinemia and hypertriglyceridemia. Diabet Med. 1999;16(1):49–54.CrossRefPubMed Gottsater A, Ahmed M, Fernlund P, Sundkvist G. Autonomic neuropathy in type 2 diabetic patients is associated with hyperinsulinemia and hypertriglyceridemia. Diabet Med. 1999;16(1):49–54.CrossRefPubMed
22.
go back to reference Laaksonen S, Voipio P, Erkinjuntti M, Asola M, Falck B. Does dialysis therapy improves autonomic and peripheral nervous system abnormalities in chronic uremia? J Int Med. 2000;248(1):21–6.CrossRef Laaksonen S, Voipio P, Erkinjuntti M, Asola M, Falck B. Does dialysis therapy improves autonomic and peripheral nervous system abnormalities in chronic uremia? J Int Med. 2000;248(1):21–6.CrossRef
Metadata
Title
Heart Rate Variability in Patients with Diabetic Nephropathy
Authors
Emam Waked
Amna Metwaly
Emad Abd Allah
Heba Sayed Assal
Khaled Younes
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Kidney / Issue 5/2009
Print ISSN: 0940-7936
Electronic ISSN: 1865-5068
DOI
https://doi.org/10.1007/s00596-009-0094-1

Other articles of this Issue 5/2009

Kidney 5/2009 Go to the issue

Nephrology in Brief

Nephrology in Brief

Nephrology in Brief

Eclectica